MyAverix Finance
US · Healthcare
Organogenesis Holdings Inc (ORGO)
Drug Manufacturers - Specialty & Generic
Organogenesis Holdings Inc (ORGO) is listed on US in the Healthcare sector. Industry: Drug Manufacturers - Specialty & Generic. As of 2026-03-23, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for ORGO
Organogenesis Holdings Inc (ORGO) — FAQ
What is ORGO's P/E ratio?
The price-to-earnings (P/E) ratio for Organogenesis Holdings Inc (ORGO) is 18.00 (data as of 2026-03-23).
Does Organogenesis Holdings Inc pay a dividend?
Dividend yield is not available in the current snapshot for Organogenesis Holdings Inc (ORGO). Check the MyAverix Finance app for the latest dividend data.
What sector is Organogenesis Holdings Inc in?
Organogenesis Holdings Inc (ORGO) is classified in the Healthcare sector (Drug Manufacturers - Specialty & Generic industry).
What exchange is ORGO listed on?
ORGO is listed on US.
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.